Silver Castle: The Economics Of The IBI Deal And The Alonim Rescue Bridge
The IBI transaction reads like a NIS 9.37 million capital injection, but note 23 shows that most of that equity is already earmarked for Alonim and officer-related liabilities. The February 2026 bridge loan did not solve the problem; it bought a short extension and left Alonim with real leverage until closing.
The main article argued that the IBI transaction is first a reset story, not proof that Silver Castle has already found a durable economic model. This follow-up isolates the arithmetic behind that claim: how much of the headline capital actually reaches the operating platform, who sits first in line before the money becomes growth capital, and why the February 2026 bridge loan changed timing and bargaining power more than it changed the underlying economics.
The core point is simple: IBI's cheque transfers control, but before it funds the future it clears the past. Note 23 says so directly. Out of the planned NIS 9.37 million equity injection, a large disclosed portion is already earmarked for roughly NIS 3.55 million owed to Alonim and NIS 4.731 million owed to officers. Before ordinary operating needs are funded, the disclosed arithmetic leaves only about NIS 1.089 million.
That is not a full cash forecast. It is just straightforward arithmetic on the uses the company itself disclosed. Even so, it tells the real story: the deal is designed first to clean up debt, governance, and control. Only after that can it become working capital or growth capital.
What IBI's Equity Cheque Actually Buys
Note 23 describes a single package: NIS 9.37 million of equity for 74.99% of the company, plus a credit line of up to NIS 10 million at a 12% annual rate. The same note also says where the money is supposed to go: repayment to Alonim, repayment of officer-related liabilities, and funding of ongoing operations, including the period before closing.
That means the equity cheque is not clean capital for the platform. It already arrives with a disclosed clean-up list attached to it:
| Use layer | Amount | Economic meaning |
|---|---|---|
| Repayment to Alonim | NIS 3.55 million | The new package first refinances the old rescue lender |
| Repayment of officer liabilities | NIS 4.731 million | A large part of the money goes to clearing legacy internal claims and enabling a cleaner control transition |
| Remainder from the equity piece alone, before ongoing operations | NIS 1.089 million | This is what is left from the equity leg before the business itself is funded |
That last number is the heart of this continuation. It does not mean the IBI credit line is irrelevant. Quite the opposite. It suggests that the line may have to do much more of the heavy lifting after closing, because the equity cheque alone is nearly spoken for before the platform gets meaningful room to breathe.
There is also a subtler point here. Note 23 frames those uses against the combined pool of equity plus the IBI credit line. So the NIS 1.089 million is not a guaranteed residual cash balance. It simply shows that the equity leg, as disclosed, is almost fully consumed by the clean-up list before the next operating phase even starts.
Alonim Still Sits First In Line
The IBI headline is about a new controlling shareholder. The actual economics begin with the old lender. In June 2025 Alonim provided a NIS 2.35 million convertible loan for ongoing activity and business development. The loan was only funded in practice on September 2, 2025, and even then it was advanced net of interest and fees. So from the start, the headline principal was larger than the operating cash that actually hit the balance sheet.
The attached valuation makes this even sharper. As of December 31, 2025, the instrument was valued at NIS 2.486 million, of which NIS 2.254 million was the liability component and NIS 232.553 thousand was the default component. The conversion component and upside component were both valued at zero. That matters. By year-end 2025 Alonim was no longer sitting on a shiny option on a recovering crypto platform. It was sitting on an instrument whose value explicitly included default risk.
The governance layer also stayed with Alonim until full repayment. The articles were amended so that Alonim may appoint either a board observer or a director, at its sole discretion, until the outstanding balance of the June 16, 2025 convertible loan is fully repaid. That helps explain why the IBI transaction report lists Alonim approvals as a condition precedent. If IBI is supposed to take 74.99% and reset the company, it still has to pass through the lender that controls the immediate bottleneck.
| Who controls the queue | What the filings disclose | Why this comes first |
|---|---|---|
| Alonim | About NIS 3.55 million to be repaid, including NIS 600 thousand not yet received as of the signing date | Existing rescue lender, a required consenting party, and holder of continuing board-level leverage until repayment |
| Officers | NIS 4.731 million expected to be repaid at closing | Part of the transaction is a clean-up of legacy internal claims, not only a business investment |
| IBI | NIS 9.37 million of equity plus up to NIS 10 million of credit | Future control and future financing power, but only once all conditions are met and the deal closes |
In plain English, Alonim is not just debt waiting to be refinanced. It is the mandatory checkpoint of the entire transaction. Anyone reading the deal only as "IBI comes in" misses that the transition first works as repayment and removal of the old rescue lender's leverage.
The Bridge Loan Bought Time, Not A Solution
At first glance, the February 5, 2026 filing looks like just another small loan. In practice, it is the document that explains how the deal is supposed to survive until closing. Alonim agreed to provide NIS 1.2 million in two monthly instalments. The loan is meant to fund ongoing operations under a budget agreed with the lender, carries 11% annual interest plus VAT, and the full interest is paid upfront. On top of that, the company pays a NIS 25 thousand documentation and expense fee, also plus VAT.
So here too, the headline principal is not the same as the net cash that reaches operations. This is short-dated and expensive rescue liquidity designed to hold the company until a hard date: March 31, 2026.
The more important point is the acceleration mechanism. If the IBI deal is not completed by March 31, 2026, or if it is cancelled, Alonim may accelerate the bridge. That makes the loan much more than a technical bridge. It is a contractual hourglass. Once it was signed, the company's near-term survival became directly tied to whether the IBI deal closes in time.
There is another subtle signal in that filing. As a condition to the loan, some officers, including Eli Mizrahi, had to undertake to return compensation amounts paid to them if the IBI deal is not completed. This is not a classic collateral package, but it does show who absorbs part of the pain first if the deal fails.
The one thing Alonim did relax was a clause from the original loan, so that a breach of the earlier restriction on incurring financial debt would not by itself trigger immediate acceleration under either the new bridge or the original loan. That waiver also says something important. The bridge was not designed to squeeze the company into a corner immediately. It was designed to keep the company alive long enough to close the IBI deal. The price of that breathing room is that near-term leverage still sits with Alonim.
What Is Actually Left For The Platform
Once that liability stack is matched against the year-end 2025 balance sheet, the picture becomes even sharper. The company ended 2025 with only NIS 231 thousand of cash, NIS 7.224 million of negative working capital, NIS 9.345 million of current liabilities, and NIS 2.446 million of negative operating cash flow.
The right comparison here is not between the NIS 9.37 million headline and a market-cap number. The right comparison is between what is left after the named clean-up items and the hole the platform still has to fund.
This chart does not say the company will burn exactly the same amount after closing. It does say that the equity residue left after the named repayments is smaller than the 2025 operating cash burn and tiny relative to the working-capital hole. So if the transaction closes, the next operating phase will likely depend not only on the equity cheque, but also on the new credit line, tighter cost discipline, and a much cleaner execution path than the company had in 2025.
That leads to the key conclusion: the IBI transaction does not solve the question of business quality. It only moves the company from one extreme point to a new test point. If it closes, the company gets a new controller, a clean-up of a large part of the old liability stack, and a credit line that can stabilize the next stage. It will still need to prove that recurring management-fee income can support a leaner organization without another emergency financing round.
Bottom Line
The IBI transaction looks large in the headline, but the economics are much less generous. Most of the equity leg is already earmarked for repayment to Alonim and settlement of officer-related liabilities. Anyone trying to understand how much money actually reaches the business should stop treating NIS 9.37 million as a pure growth-capital number.
The new point from this continuation is not merely that the company is financially stressed. That was already visible. The sharper point is that the Alonim bridge turned the situation from a strategic negotiation into a hard timing equation: by March 31, 2026 the IBI deal has to close, otherwise the same lender keeping the company alive can accelerate the debt. So even though future control is marked for IBI, present-time bargaining power still sits with Alonim.
If the deal closes, this will first be a reset of debt, control, and management. Only after that does the real test begin for the investment-management platform itself: whether enough capital and enough operating runway remain to turn Silver Castle from a rescue transaction into a business that lives off its own activity.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.